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A protein showing strong antiviral activity against Bombyx mori nucleopolyhedrovirus (BmNPV) was purified from the digestive juice of
B. mori larvae. The molecular mass of this protein was 24271 Da. Partial N-terminal amino acid sequence of the protein was determined and
cDNA was cloned based on the amino acid sequence. A homology search of the deduced amino acid sequence of the cDNA showed 94%
identity with B. mori serine protease so the protein was designated B. mori serine protease-2 (BmSP-2). Analysis of BmSP-2 gene expression
showed that this gene is expressed in the midgut but not in other tissues. In addition, BmSP-2 gene was shown to not be expressed in the
molting and wandering stages, indicating that the gene is hormonally regulated. Our results suggest that BmSP-2, an insect digestive enzyme,
can be a potential antiviral factor against BmNPV at the initial site of viral infection.
D 2004 Elsevier Inc. All rights reserved.Keywords: Bombyx mori; BmSP-2; AntiviralIntroduction
Many antiviral molecules other than interferons and
antibodies have been reported in vertebrates (Asano et al.,
2002; Murphy et al., 2000; Nozaki et al., 2003; Reading et
al., 1998; Siciliano et al., 1999; Singh et al., 1999). On the
other hand, immune reactions against viral pathogens in
invertebrates remain obscure. As invertebrates possess no
acquired immunity and the occurrence of interferons has not
been reported from invertebrates, it is speculated that
invertebrates have other immune factors to fight viral
pathogens.
Tachyplesin I, a cationic peptide composed of 17 amino
acid residues from horseshoe crab, Tachypleus tridentatus,
hemocytes was found to show antiviral activity against
vesicular stomatitis virus (Murakami et al., 1991) and
human immunodeficiency virus (HIV) (Morimoto et al.,
1991) although the horseshoe crab is not a host for these0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2003.12.011
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mosquito, Aedes albopictus, cells persistently infected with
Banzi virus possessed the ability to suppress the replication
of Banzi virus and contained two proteins of similar
molecular weight (Lee and Schloemer, 1981). However,
no amino acid sequence analysis of these antiviral factors
was conducted. In addition, a protein that showed antiviral
activity against Semiliki Forest virus was purified to ho-
mogeneity from A. albopictus cultured cells (Luo and
Brown, 1993). This 3.2-kDa antiviral protein was extremely
hydrophobic and the amino-terminus blocked (Luo and
Brown, 1993). Although the effect of the 3.2-kDa mosquito
antiviral protein on virus replication was studied, the amino
acid sequence and gene expression patterns of this protein
were not analyzed. Insect antimicrobial peptides melittin
and cecropin were shown to inhibit replication of HIV by
suppressing viral gene expression (Wachinger et al., 1998)
and alloferon from the blow fly Calliphora vicina showed
antiviral activity against influenza viruses A and B (Cher-
nysh et al., 2002).
The silkworm Bombyx mori has also been used to study
antiviral factors because viral infection often causes large
losses in silk production. The presence of antiviral sub-
Fig. 2. Effect of BmSP-2 dose on BmNPV-ODV infectivity. ODV
infectivity was examined after treatment of ODV (860 ng per larva) with
different concentration of BmSP-2. Data shown are means F SD of results
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the gut juice of the silkworm has been reported (Aizawa,
1962; Funakoshi and Aizawa, 1989a; Hayashiya et al.,
1971; Hayashiya et al., 1968), but these substances were
not identified. A viral inhibitory factor (VIF) produced in
B. mori hemolymph was also detected and this fatty acid-
based VIF inactivated BmNPV in vitro but did not show
prophylactic or curative properties when injected into
infected B. mori pupae (Funakoshi and Aizawa, 1989b).
Therefore, the primary function of this compound may not
be antiviral. A red fluorescent protein (RFP) in B. mori gut
juice was first reported by Mukai et al. (1969) and found
to possess antiviral activity against BmNPV (Hayashiya et
al., 1968). The RFP was demonstrated to be produced in
vitro from three components: a protein from the midgut of
larvae, chlorophyll-a, and a basic protein from the chloro-
plast of green leaves (Hayashiya et al., 1976a). Chloro-
phyllide-a derived from chlorophyll-a rather than a protein
consisting of the RFP was suggested to play an essential
role in antiviral activity against BmNPV (Hayashiya et al.,Fig. 1. (A) Final HPLC purification profile of BmSP-2. BmSP-2 was eluted
with 49.5% acetonitrile/0.05% TFA by reverse-phase HPLC. The arrow
indicates the position of BmSP-2. (B) The LC-MS spectrum with molecular
mass of BmSP-2.
from five experiments. Luciferase activity was measured at 136 hpi.
Luciferase activity of hemolymph samples from nontreated B. mori larvae
was determined as a background and the level of relative light units (RLU)
per 10 Al of hemolymph was 120 F 3.4.1976a, 1976b). A different RFP (65 kDa) having antiviral
activity against BmNPV was also purified (Nagaraja-
Sethuraman et al., 1993). A substance detected in an
extract of silkworm faeces was shown to markedly sup-
press production of Sendai virus, herpes simplex virus
type-1, and HIV (Hiraki et al., 1996). The active substance
was partially purified and sugars were also detected with
lectin blotting (Hiraki et al., 1996). In addition, a chloro-
phyll-like substance from silkworm faeces was demonstrat-
ed to have clear antiviral activity against Sendai virus,
herpes simplex virus, and HIV (Hiraki et al., 1997). It has
also been shown that the hemagglutinating activity of B.
mori hemolymph increased when silkworms were infectedTable 1




Mortalityb (%) Pupation (%)
I II I II I II
None 1.04  102 2.50  102 0 0 100 100
Control ODV 1.01  108 9.95  107 100 100 0 0
ODV + BmSP-2 1.29  102 6.76  102 0 0 100 100
RLU: relative light units. None: non-treated larva. Control ODV: ODV
(22.5 ng per larva) treated with 40 mM phosphate buffer, pH 7.4, was used
as a control. ODV + BmSP-2: ODV (22.5 ng per larva) was incubated with
BmSP-2 (2.2 Ag per larva). Five larvae were used for each mortality and
pupation test. Experimental conditions are described in detail in Materials
and methods.
a Luciferase activity was measured at 136 hpi and is expressed as the mean
of activities from 30 individual larvae.
b Mortality was checked at 168 hpi.
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1989).
To date, the primary structure, antiviral specificity, and
gene expression of antiviral proteins from invertebrates in
immune reactions against viral pathogens have not been
fully elucidated. Thus, we aimed to identify antiviral pro-
teins from the digestive juice of B. mori larvae to analyze
their role in the immune responses against viral pathogens at
an early stage of viral infection. Here, we report the
purification, cDNA cloning, and gene expression of a
digestive enzyme that shows strong antiviral activity against
BmNPV-occlusion-derived virus (ODV).Fig. 3. Nucleotide and deduced amino acid sequences of BmSP-2 cDNA. The putat
termination codon (TAA). The polyadenylation signals are underlined. The nucleo
GenBank Data Libraries under accession number AB117641.Results
Purification and antiviral activity of an antiviral protein
An antiviral protein factor against BmNPV-ODV was
partially purified from the digestive juice of B. mori larvae
by 40% ammonium sulphate fractionation. The ammonium
sulphate fraction was further purified by gel-filtration and
reverse-phase high performance liquid column chromatog-
raphy (HPLC). Antiviral activity was monitored using
BmNPV containing a luciferase reporter gene driven by a
p10 promoter (Tomita et al., 1995). An aliquot of eachive signal sequence of purified BmSP-2 is underlined. An asterisk shows the
tide sequence of BmSP-2 has been deposited with the DDBJ, EMBL, and
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luciferase gene and B. mori larvae were orally inoculated
with this mixture. Hemolymph was collected from larvae at
136 h postinfection (hpi) and luciferase activity derived
from budded virus (BV) was measured. Note that virus
particles present in the hemolymph are BVs originated from
ODVs containing the luciferase gene. Two main antiviral
peaks were detected at 13.5 and 21 min in the final reverse-
phase HPLC (Fig. 1A). The antiviral peak eluted at 21 min
was previously analyzed and found to be lipase (Ponnuvel et
al., 2003). Thus, another antiviral peak eluted at 13.5 min
with 39.5% acetonitrile/0.05% trifluoroacetic acid (TFA)
was analyzed in this work. The purity of the antiviral
substance in this peak fraction was examined by both liquid
chromatography-mass spectrometry (LC-MS) and matrix-
assisted laser desorption/ionization time of flight mass
spectrometry (MALDI-TOF-MS). The results showed this
fraction contained a single protein and its molecular mass
determined by LC-MS and MALDI-TOFF-MS was 24271
Da (Fig. 1B).
Effect of the antiviral protein dose on BmNPV-ODV
infectivity was analyzed. Results showed that the infectivity
of ODV treated with 0.48 or 0.97 Ag per larva of this
antiviral protein was very high but dramatically deceased
when the virus was treated with high concentration of this
protein (more than 1.94 Ag per larva) (Fig. 2). Infectivity of
ODV treated with more than 3.89 Ag/ml of the protein was
at a background level.
Mortality and pupation were also examined after ODV
was treated with the purified antiviral protein. The purified
protein (2.2 Ag per larva) was incubated with ODV (22.5 ngFig. 4. Comparison of the amino acid sequences between BmSP-2 and other enz
residues show identity, are boxed in black. The active site of the enzymes is showper larva) and B. mori larvae were inoculated orally with the
mixture to investigate the antiviral activity. Luciferase
activity derived from budded virus (BV) was measured after
hemolymph was collected. If the purified protein does not
show antiviral activity against ODV, the luciferase activity
level in the hemolymph should be comparable with that of
the sample from larvae inoculated with control ODV treated
with phosphate buffer. The results showed the luciferase
activity was at a background level (Table 1), whereas the
control ODV sample revealed very high luciferase activity
(Table 1). All fifth-instar larvae inoculated with ODV
treated with this protein entered the pupal stage, although
all control larvae inoculated with control ODV died within
168 hpi (Table 1). These results indicate the purified protein
has strong antiviral activity against ODV.
cDNA cloning and comparison of the amino acid sequence
The purified protein was subjected to analysis of N-
terminal amino acid sequence. The amino acid sequence
determined was NH2-IVGGSAANAGAHPHLAGLVI. Ho-
mology search of this amino acid sequence was conducted
using B. mori expressed-sequenced tag (EST) database.
Four EST clones (mg0688, mg103, mg564, and mg994)
were found to have an identical sequence. Full-length
nucleotide sequences of these clones were determined and
the complete amino acid sequence deduced (data not
shown). Proteins deduced from these four clones showed
the amino acid sequences have high similarity, suggesting
they are isoforms (data not shown). Of these four clones,
mg103 was found to encode 284 amino acid residues and 50ymes. Identical amino acid residues, in which more than three out of five
n with asterisks. An arrow indicates the cleavage site for mature proteins.
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removed to produce the mature protein (Fig. 3). Molecular
mass of this mature peptide was calculated to be 24276,
coincident with the measured masses by LC-MS and
MALDI-TOF-MS. Molecular masses of the mature proteins
deduced from mg0688, mg564, and mg994 clones were
different from that of the purified protein. Thus, we con-
cluded the mg103 clone is derived from mRNA encoding
the purified antiviral protein. Computer-aided homology
search for the deduced amino acid sequence of this protein
showed that it had 94% identity with a B. mori serine
protease (Kotani et al., 1999) (Fig. 4). In addition, this
protein showed a strong relationship to the primary structure
of cotton bollworm (Helicoverpa armigera) chymotrypsin-
like protease (Bown et al., 1997), corn earworm (Helico-
overpa zea) chymotrypsinogen (Mazumdar-Leighton and
Broadway, 2001), and tobacco hornworm (Manduca sexta)
chymotrypsin (Peterson et al., 1995). Active sites of these
proteins are completely conserved (Fig. 4). In addition,
protease activity of the purified antiviral protein was con-Fig. 5. (A) Tissue-specific gene expression of BmSP-2. BmSP-2 gene expression
hemocyte (H), midgut (MG), Malpighian tubule (MP), silk gland (S), and trachea
BmSP-2 gene expression in the different portions of the midgut by RT-PCR. Total
(P) of the midgut. (C) BmSP-2 gene expression in fourth- and fifth-instars. Northe
by ethidium bromide staining. Fourth-instar larvae on days 5 and 6 are the moltin
infection on BmSP-2 gene expression. BmSP-2 gene expression was analyzed atfirmed (data not shown). The purified protein was thus
designated B. mori serine protease-2 (BmSP-2) based on
these results.
Gene expression of BmSP-2
Tissue specificity of BmSP-2 gene expression was ana-
lyzed by reverse transcriptase-polymerase chain reaction
(RT-PCR). BmSP-2 gene was expressed exclusively in the
midgut and no expression of this gene was detected in the
fat body, hemocyte, Malpighian tubule, silk gland, and
trachea (Fig. 5A). The midgut was further separated into
three portions and BmSP-2 gene expression examined.
BmSP-2 gene was expressed in the anterior, middle, and
posterior portion of the midgut (Fig. 5B). BmSP-2 gene
expression in fourth- and fifth-instar larvae was analyzed by
Northern blotting. The results showed that gene expression
strongly declines at the molting stage between fourth and
fifth instars and at the wandering stage just before pupation
(fifth instar 7 days) (Fig. 5C). Inducibility of BmSP-2 genewas analyzed by RT-PCR. Total RNA was extracted from the fat body (F),
(T). As an internal marker, actin gene was also analyzed. (B) Analysis of
RNAwas extracted from the anterior (A), middle (M), and posterior portion
rn blotting was conducted. As an internal marker, 28S rRNAwas visualized
g stages. Fifth-instar day 7 is the wandering stage. (D) Effects of BmNPV
different time intervals after BmNPV infection by Northern blotting.
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Northern blotting. The results showed that BmSP-2 gene
is expressed regardless of BmNPV infection (Fig. 5D).Fig. 6. Effect of different concentrations of BmNPV-ODVon the mortality
of B. mori larvae. Each fifth-instar larva just after ecdysis was orally
infected with the indicated concentration of ODV. Mortality was checked at
168 hpi. The data shown are the typical result of three independent
experiments.Discussion
BmNPV was chosen as a model virus to examine insect
immune mechanisms against viral infection. NPVs are
double-stranded DNA viruses belonging to the family
Baculoviridae. NPVs require two phenotypically different
but genetically identical virions to complete their life cycle
(Engelhard and Volkman, 1995; Maeda, 1989; Trudeau et
al., 2001). Both forms perform a different role during
pathogenesis. An ODV initiates primary infection within
the midgut of hosts following ingestion. The second virion
phenotype, BV, buds out of the midgut cells and transmits
infection from cell to cell within the host. Therefore,
immune mechanisms in hosts against ODV and BV are
speculated to be different.
We purified a protein showing strong antiviral activity
against BmNPV-ODV from the digestive juice of B. mori
larvae. A cDNA encoding this protein was cloned to deduce
the full amino acid sequence. BmSP-2 showed 94% amino
acid sequence identity with a serine protease from B. mori
digestive juice (Kotani et al., 1999). The serine protease had
an isoelectric point of pH 10–11 and the pH optimum for
degradation activity of sucinyl-Leu-Val-Tyr-MCAwas about
10 (Kotani et al., 1999). The pH optimum of BmSP-2 was
also determined to be about 11 showing this enzyme is a
highly basic protease (data not shown). A sequence com-
parison of BmSP-2 with other proteases indicated that
BmSP-2 is a mammalian-type serine protease with a cata-
lytic triad composed of His 45, Asp 92, and Ser 186 (Fig. 3).
A large number of Arg may contribute to the stability and
function of BmSP-2 by remaining charged at a high pH as
suggested by Kotani et al. (1999).
A final yield of the pure BmSP-2 from 200 larvae was
estimated to be 116.8 Ag, showing that a larva contains
approximately 0.58 Ag BmSP-2. On the other hand, the
LD50 of ODV was determined to be 12.0 ng per larva with
95% confidence limits between 10.6 and 13.7 ng per larva
(Fig. 6). The LD50 was also confirmed by amortality of 100%
in B. mori larvae infected with 22.5 ng ODV (Table 1). The
effect of BmSP-2 concentration on a fixed amount of ODV
(860 ng per larva) was examined. The results showed that
ODV treated with more than 3.89 Ag of BmSP-2/larva cannot
propagate at all (Fig. 2). These data suggest the physiological
concentration of BmSP-2 cannot protect against infection
with 22.5 ng of ODV, although the same amount of ODV can
be completely inactivated by 2.2 Ag of BmSP-2 (Table 1).
Nonetheless, BmSP-2 is speculated to inactivate a portion of
ODV when a larva is infected with less than 22.5 ng of ODV.
In fact, the mortality was 20% for larvae infected with 11 ng
of ODV per larva and no larvae died when infected with less
than 5.5 ng of ODV per larva (Fig. 6). We recently demon-strated a lipase designated Bmlipase-1 from B. mori digestive
juice showing a strong antiviral activity against BmNPV-
ODV (Ponnuvel et al., 2003), suggesting that digestive
enzymes such as BmSP-2 and Bmlipase-1 contribute as
physiological barriers to inactivation of BmNPV-ODV at
the initial infection site in B. mori larvae.
BmSP-2 gene was shown to be expressed only in the
midgut (Fig. 5). As described above, at least five serine
protease isoforms including BmSP-2 are assumed to occur
in B. mori. Moreover, the results of Southern blotting
indicate that B. mori has more serine protease isoforms
(data not shown), suggesting they form a gene family. It
seemed to be difficult to distinguish expression of each gene
from this family by Northern blotting used in this work.
Thus, RT-PCR using BmSP-2 specific primers was con-
ducted and the positive signals in Northern blotting were
confirmed (data not shown). Results of Northern blot
analysis suggest that expression of the family genes is
regulated simultaneously. The family genes were constitu-
tively expressed regardless of BmNPV infection but gene
expression strongly diminished both at the molting stage
and the wandering stage just before pupation (Fig. 5),
suggesting the family genes including BmSP-2 gene are
hormonally regulated. However, a possibility that mRNA
for BmSP-2 is simply unstable at the molting stage and
wandering stage cannot be ruled out at present. The BmSP-2
gene expression pattern analyzed by RT-PCR is the same as
for Bmlipase-1 gene (Ponnuvel et al., 2003), except for the
expression pattern in the posterior portion of the midgut,
suggesting that both genes have different regulatory mech-
anisms in the posterior portion of the midgut. Our gene
expression analysis suggests the main physiological role of
both digestive enzymes is food digestion. Our results,
however, also suggest that these digestive enzymes have
potential to inactivate BmNPV.
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Bmlipase-1 against ODV remain unclear at present, it is
conceivable that inactivation of ingested viruses by diges-
tive enzymes at the initial infection site before they propa-
gate in the midgut and spread into hemocoel is an efficient
strategy for host defense in B. mori. Thus, suppression of
ODV attachment to midgut epithelial cells by digestive
enzymes in the alimentary canal may provide an attractive
mechanism to protect larvae from BmNPV infection. Anal-
ysis of antiviral mechanisms of these digestive enzymes
against BmNPV-ODV may shed light on the insect immune
response against viruses at the initial infection site.Materials and methods
Insects
All B. mori larvae used in this study were collected from
the silkworm germplasm station of the National Institute of
Agrobiological Sciences, Kobuchisawa, Yamanashi, Japan.
B. mori larvae of the Daizo race were reared on mulberry
leaves, whereas larvae of Tokai  Asahi race were fed on an
artificial diet (Nihonnosanko). The silkworms were main-
tained in a silkworm-rearing room under controlled envi-
ronmental conditions at 27 jC.
Purification of BmSP-2
The purification procedure depended on previously
published methods by Ponnuvel et al. (2003). Briefly,
ammonium sulphate was added to the collected digestive
juice from Daizo race larvae by mild electric shock to give
40% saturation. The precipitate was suspended in 40 mM
phosphate buffer at pH 7.4 and treated with 50% n-butanol
(final concentration) overnight at 4 jC. The lower aqueous
layer was collected after centrifugation for 30 min at
10000  g. Half-volume ice-cold acetone was added to
the solution to precipitate proteins in the aqueous layer.
The precipitated proteins were collected by centrifugation
for 30 min at 10000  g and dried. The proteins dissolved
in 40 mM phosphate buffer, pH 7.4, were applied to a
Superdex 200 HR 10/30 column attached to a FPLC
system (Pharmacia) and equilibrated with the same buffer.
Antiviral activity in each fraction was tested. Fractions
showing antiviral activity were further purified through a
reverse-phase column, Sephasil C8 SC 2.1/10 attached to a
SMART system (Pharmacia) with a linear gradient of
acetonitrile/0.05% TFA.
Antiviral activity of BmSP-2 against BmNPV-ODV
The antiviral activity was assayed using BmNPVp10luc,
which contains a luciferase reporter gene driven by a p10
promoter (Tomita et al., 1995). The recombinant BmNPV
was obtained from Dr. Shuichiro Tomita from our institute.The recombinant virus expresses a luciferase reporter gene
at 15 hpi. B. mori Tokai  Asahi race was used to quantify
the infection and mortality levels. The ODV was purified by
ultracentrifugation on sucrose gradient (Summers and
Smith, 1978). The ODV suspension was mixed with
BmSP-2 dissolved in 40 mM phosphate buffer at pH 8.0
and incubated at 30 jC for 1 h. Different concentrations of
BmSP-2 were incubated with ODV (860 ng per larva) to
examine the dose effect on ODV infectivity. The ODV (22.5
ng per larva) was mixed with BmSP-2 (2.2 Ag per larva) to
examine the mortality and pupation rates of B. mori larvae.
Fifth-instar larvae just after ecdysis were used to orally
inoculate the ODV mixture (5 Al). Ten microliters of
hemolymph collected at 136 hpi was added to 50 Al of
luciferase assay buffer (Promega) and luciferase activity was
measured by a Luminocounter 700 (Microtech-Nition).
cDNA cloning and nucleotide sequencing of BmSP-2
The expressed-sequenced tag (EST) database of B.
mori (silkbase; http://www.ab.a.u-tokyo.ac.jp/silkbase/)
was screened taking advantage of the N-terminal amino
acid sequence of the purified protein. Clones designated
mg0688, mg103, mg564, and mg994 from the midgut
cDNA library showed homology with this protein. These
clones were kindly provided by Dr. Kazuei Mita from our
institute. The nucleotide sequences of these clones were
determined and found to lack the sequence of the 5V
region. mRNA extracted from the midgut and purified
by a Quick Prep mRNA Kit (Amersham Pharmacia
Biotech) was used to obtain a complete nucleotide se-
quence by a First Choice RLM-RACE Kit (Ambion). The
nucleotide sequence was determined by dye-terminator
cycle sequencing using a DNA sequencer (ABI 373A).
Analysis of BmSP-2 gene expression
Tissues such as the midgut, hemocyte, silk gland, tra-
chea, fat body, and Malpighian tubules were prepared from
fifth-instar 2-day larvae. The midgut was further separated
into anterior, middle, and posterior portions. Total RNA
from each tissue was isolated with ISOGEN (Nippon Gene).
First-strand cDNA was synthesized with 5 Ag of total RNA
using a First-Strand cDNA Synthesis Kit (Amersham). RT-
PCR was conducted under the following conditions: 94 jC
for 1 min and then 15 cycle reactions (94 jC for 30 s, 55 jC
for 30 s, and 72 jC for 30 s). The following BmSP-2
specific primers were used: 5V-ACTGCTGGAGGTCCA-
GGGAT-3V (forward primer) and 5V-GGTGGAGCCAAT-
GATCAGAG-3V (reverse primer). As an internal control,
actin gene was also analyzed using the following primers:
5V-AGCAGGAGATGGCCACC-3V (forward primer) and 5V-
TCCACATCTGCTGGAAGG-3V(reverse primer). Northern
blotting (Sambrook et al., 1989) was conducted with 20 Ag
total RNA and screened with a Digoxygenine (DIG)-labeled
BmSP-2 probe prepared by PCR DIG Labeling Mix
H. Nakazawa et al. / Virology 321 (2004) 154–162 161(Roche). BmSP-2 gene expression was analyzed at different
time intervals in the life cycle or after BmNPV infection.
Effect of increasing amounts of BmNPV-ODV on the
mortality of B. mori larvae
Each fifth-instar larva just after ecdysis was orally inoc-
ulated with different amounts of ODVand the mortality was
determined at 168 hpi. LD50 of ODV was calculated by the
computer program PriProbit (version 1.63) by M. Sakuma.Acknowledgments
We thank Dr. Toru Arakawa and Dr. Yoji Furuta in our
institute for their technical advice. This work was supported
in part by the Program for Promotion of Basic Research
Activities for Innovative Biosciences of the Bio-Oriented
Technology Research Advancement Institution, Japan, and
by Grants-in-Aid (Bio Design Program and Insect Technol-
ogy Program) from the Ministry of Agriculture, Forestry
and Fisheries of Japan.References
Aizawa, K., 1962. Antiviral substance in the gut-juice of the silkworm,
Bombyx mori (Linnaeus). J. Insect Pathol. 4, 72–76.
Asano, A., Ko, J.H., Morozumi, T., Hamashima, N., Watanabe, T., 2002.
Polymorphisms and the antiviral property of Mx1 protein. J. Vet. Med.
Sci. 64, 1085–1089.
Bown, D.P., Wilkinson, H.S., Gatehouse, J.A., 1997. Differentially regu-
lated inhibitor-sensitive and insensitive protease genes from the phy-
tophagous insect pest, Helicoverpa armigera, are members of complex
multigene families. Insect Biochem. Mol. Biol. 27, 625–638.
Chernysh, S., Kim, S.I., Bekker, G., Pleskach, V.A., Filatova, N.A., Anikin,
V.B., Platino, V.G., Bullet, P., 2002. Antiviral and antitumor peptides
from insects. Proc. Natl. Acad. Sci. U.S.A. 99, 12628–12632.
Engelhard, E.K., Volkman, L.E., 1995. Developmental resistance in forth
instar Trichoplusia ni orally inoculated with Autographa californica M
nuclear polyhedrosis virus. Virology 209, 384–389.
Funakoshi, M., Aizawa, K., 1989a. Antiviral substance in the silkworm gut
juice against a nuclear polyhedrosis virus of the silkworm, Bombyx
mori. J. Invertebr. Pathol. 53, 135–136.
Funakoshi, M., Aizawa, K., 1989b. Viral inhibitory factor produced in the
hemolymph of the silkworm, Bombyx mori, infected with a nuclear
polyhedrosis virus. J. Invertebr. Pathol. 54, 151–155.
Hayashiya, K., Nishida, J., Matsubara, F., 1968. Inactivation of nuclear
polyhedrosis virus in the digestive juice of silkworm larvae, Bombyx
mori L: I. Comparison of anti-viral activities in the digestive juice of
larvae reared on natural and artificial diets. J. Appl. Entomol. Zool. 12,
189–193 (in Japanese).
Hayashiya, K., Matsubara, F., Nishida, J., Kawamoto, F., 1971. Compara-
tive experiments with the silkworm larvae reared on mulberry leaves
and artificial diets: I. Comparison of antiviral activities in the digestive
juice of larvae reared on natural and artificial diets. Bull. Fac. Text. Sci.
Kyoto Univ. Ind. Arts Text. Fibers 6, 87–100.
Hayashiya, K., Nishida, J., Uchida, U., 1976a. The mechanism of forma-
tion of the red fluorescent protein in the digestive juice of silkworm
larvae—The formation of chlorophyllide-a. J. Appl. Entomol. Zool. 20,
37–43 (in Japanese).
Hayashiya, K., Uchida, U., Nishida, J., 1976b. Comparison of anti-viralactivities of the silkworm larvae reared in light and in darkness in
relation to the formation of red fluorescent protein (RPF). J. Appl.
Entomol. Zool. 20, 139–143 (in Japanese).
Hiraki, A., Ikuno, Y., Kim, J., Ueda, S., 1996. Suppression of enveloped
virus production with a substance from silkworm faeces. Cell Struc.
Funct. 21, 501–514.
Hiraki, A., Yukawa, M., Kim, J., Ueda, S., 1997. Antiviral substance from
silkworm faeces: purification and its chemical characterization. Biol.
Pharm. Bull. 20, 547–555.
Kotani, E., Niwa, T., Tokizane, M., Suga, K., Sugimura, Y., Oda, K., Mori,
M., Furusawa, T., 1999. Cloning and sequence of a cDNA for a highly
basic protease from the digestive juice of the silkworm, Bombyx mori.
Insect Mol. Biol. 8, 299–304.
Lee, C.H., Schloemer, R.H., 1981. Identification of the antiviral factor in
culture medium of mosquito cells persistently infected with Banzi virus.
Virology 110, 445–454.
Luo, T., Brown, D.T., 1993. Purification and characterization of a Sindbis
virus-induced peptide which stimulates its own production and blocks
virus RNA synthesis. Virology 194, 44–49.
Maeda, S., 1989. Expression of foreign genes in insects using baculovirus
vectors. Annu. Rev. Entomol. 34, 351–372.
Mazumdar-Leighton, S., Broadway, R.M., 2001. Identification of six chy-
motrypsin cDNAs from larval midguts of Helicoverpa zea and Agrotis
ipsilon feeding on the soybean (Kunitz) trypsin inhibitor. Insect Bio-
chem. Mol. Biol. 31, 633–644.
Mori, H., Ohyane, M., Ito, M., Iwamoto, S., Matsumoto, T., Sumida, M.,
Matsubara, F., 1989. Induction of a hemagglutinating activity in the
hemolymph of the silkworm, Bombyx mori, infected with cytoplasmic
polyhedrosis virus. J. Invertebr. Pathol. 54, 112–116.
Morimoto, M., Mori, H., Otake, T., Ueba, N., Kunita, N., Niwa, M., Mur-
akami, T., Iwanaga, S., 1991. Inhibitory effect of tachyplesin I on the
proliferation of human immunodeficiency virus in vitro. Chemotherapy
37, 206–211.
Mukai, J., Inoue, J., Akune, S., 1969. A red, fluorescent protein from
silkworm. Agric. Biol. Chem. 33, 125–127.
Murakami, T., Niwa, M., Tokunaga, F., Miyata, T., 1991. Direct virus
inactivation of tachyplesin I and its isopeptides from horseshoe crab
hemocytes. Chemotherapy 37, 327–334.
Murphy, M.E., Kariwa, H., Mizutani, T., Arikawa, J., Takashima, I., 2000.
In vitro antiviral activity of lactoferrin and ribavirin upon hantavirus.
Arch. Virol. 145, 1571–1582.
Nagaraja-Sethuraman, B., Nagaraju, N., Datta, R.K., 1993. Purification and
partial characterization of antiviral protein in silkworm, Bombyx mori.
Indian J. Seric. 32, 63–67.
Nozaki, A., Ikeda, M., Naganuma, A., Nakamura, T., Inudoh, M., Tanaka,
K., Kato, N., 2003. Identification of a lactoferrin-derived peptide pos-
sessing binding activity to hepatitis C virus E2 envelope protein. J. Biol.
Chem. 278, 10162–10173.
Peterson, A.M., Fernando, G.J.P., Wells, M.A., 1995. Purification, charac-
terization and cDNA sequence of an alkaline chymotrypsin from the
midgut of Manduca sexta. Insect Biochem. Mol. Biol. 25, 765–774.
Ponnuvel, K.M., Nakazawa, H., Furukawa, S., Asaoka, A., Ishibashi, J.,
Tanaka, M., Yamakawa, M., 2003. A lipase isolated from the silkworm
Bombyx mori shows antiviral activity against nucleopolyhedrovirus.
J. Virol. 77, 10725–10729.
Reading, P.C., Holmskov, U., Anders, E.M., 1998. Antiviral activity of
bovine collectins against rotaviruses. J. Gen. Virol. 79, 2255–2263.
Sambrook, J., Fritisch, E.F., Maniatis, T., 1989. Molecular Cloning: A
Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold
Spring Harbor, NY.
Siciliano, R., Rega, B., Marchetti, M., Seganti, L., Antonini, G., Valenti, P.,
1999. Bovine lactoferrin peptidic fragments involved in inhibition of
herpes simplex virus type I infection. Biochem. Biophys. Res. Com-
mun. 264, 19–23.
Singh, I.P., Chopra, A.K., Coppenhaver, D.H., Ananatharamaiah, G.M.,
Baron, S., 1999. Lipoproteins account for part of the broad non-specific
antiviral activity of human serum. Antiviral Res. 42, 211–218.
H. Nakazawa et al. / Virology 321 (2004) 154–162162Summers, M.D., Smith, G.E., 1978. Baculovirus structural polypeptides.
Virology 84, 390–402.
Tomita, S., Kanaya, T., Kobayashi, J., Imanishi, S., 1995. Isolation of p10
gene from Bombyx mori nuclear polyhedrosis virus and study of its
promoter activity in recombinant baculovirus vector system. Cytotech-
nology 17, 65–70.
Trudeau, D., Washburn, J.O., Volkman, L.E., 2001. Central role of hemo-cytes in Autographa californica M nucleopolyhedrovirus pathogenesis
in Heliothis virescens and Helicoverpa zea. J. Virol. 75, 996–1003.
Wachinger, M., Kleinschmidt, A., Winder, D., von Pechmann, N., Ludvig-
sen, A., Neumann, M., Holle, R., Salmons, B., Erfle, V., Brack-Werner,
R., 1998. Antimicrobial peptides melittin and cecropin inhibit replica-
tion of human immunodeficiency virus 1 by suppressing viral gene
expression. J. Gen. Virol. 79, 731–740.
